Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer

Published:2021-07 Issue:3 Volume:110 Page:738-741
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Marcq Gautier,Souhami Luis,Cury Fabio L.,Salimi Afsar,Aprikian Armen,Tanguay Simon,Vanhuyse Marie,Rajan Raghu,Brimo Fadi,Mansure José João,Kassouf Wassim

Funder

Roche

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference11 articles.

1. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer;Powles;Nature,2014

2. Pembrolizumab as second-line therapy for advanced urothelial carcinoma;Bellmunt;N Engl J Med,2017

3. Anti-PD-L1 antibody active in metastatic bladder cancer;Brower;Lancet Oncol,2015

4. Radiation meets immunotherapy: A perfect match in the era of combination therapy?;Soukup;Int J Radiat Biol,2015

5. PD-1/PD-L1 Immune-Checkpoint Inhibition with Radiation in Bladder Cancer: In Situ and Abscopal Effects;Rompré-Brodeur;Mol Cancer Ther,2019

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder sparing options for muscle-invasive bladder cancer;Current Opinion in Urology;2024-09-03

2. Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study;International Journal of Radiation Oncology*Biology*Physics;2024-07

3. Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer;World Journal of Urology;2024-04-04

4. Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer;British Journal of Pharmacology;2024-01-16

5. Efficacy and Safety of Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Interim Analysis from a Multicenter, Open-label, Prospective Phase 2 Trial;International Journal of Radiation Oncology*Biology*Physics;2023-11